NCT04881682View on ClinicalTrials.gov

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

PHASE2RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

CIDP

Interventions

DEVICE

Immunoadsorption

see arm/group description

BIOLOGICAL

Immunoglobulins

see arm/group description

Trial Locations (1)

89081

RECRUITING

Department of Neurology, University of Ulm, Ulm

Sponsors

Collaborators (1)

Miltenyi Biomedicine GmbH

All Listed Sponsors

collaborator

Miltenyi Biomedicine GmbH

INDUSTRY

lead

University of Ulm

OTHER